Miguel Viveiros Selected Research

Thioridazine (Mellaril)

1/2017	Thioridazine: A Non-Antibiotic Drug Highly Effective, in Combination with First Line Anti-Tuberculosis Drugs, against Any Form of Antibiotic Resistance of Mycobacterium tuberculosis Due to Its Multi-Mechanisms of Action.
5/2012	Why thioridazine in combination with antibiotics cures extensively drug-resistant Mycobacterium tuberculosis infections.
12/2011	Thioridazine induces apoptosis of multidrug-resistant mouse lymphoma cells transfected with the human ABCB1 and inhibits the expression of P-glycoprotein.
5/2011	Effective therapy with the neuroleptic thioridazine as an adjunct to second line of defence drugs, and the potential that thioridazine offers for new patents that cover a variety of "new uses".
12/2009	The role of efflux pumps in macrolide resistance in Mycobacterium avium complex.
7/2006	"Non-Antibiotics": alternative therapy for the management of MDRTB and MRSA in economically disadvantaged countries.
7/2005	The in vitro activity of phenothiazines against Mycobacterium avium: potential of thioridazine for therapy of the co-infected AIDS patient.
11/2004	Antimicrobial activity of phenothiazines.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Miguel Viveiros Research Topics

Disease

33	Tuberculosis (Tuberculoses) 12/2021 - 09/2002
22	Infections 05/2019 - 09/2002
12	Extensively Drug-Resistant Tuberculosis 01/2021 - 04/2008
11	Multidrug-Resistant Tuberculosis (Drug-Resistant Tuberculosis) 01/2022 - 09/2005
10	Neoplasms (Cancer) 04/2020 - 05/2003
6	Lymphoma (Lymphomas) 01/2016 - 06/2009
3	Communicable Diseases (Infectious Diseases) 10/2020 - 01/2014
3	Coinfection 01/2020 - 01/2017
3	Acquired Immunodeficiency Syndrome (AIDS) 12/2009 - 07/2005
2	Pulmonary Tuberculosis 01/2017 - 03/2003
2	Psychotic Disorders (Schizoaffective Disorder) 12/2011 - 07/2006
1	COVID-19 04/2022
1	Breast Neoplasms (Breast Cancer) 01/2019
1	Leprosy (Hansen's Disease) 01/2018
1	Bacterial Infections (Bacterial Infection) 01/2017
1	Psoas Abscess 11/2016
1	Carcinoma (Carcinomatosis) 10/2011
1	Colonic Neoplasms (Colon Cancer) 10/2011
1	Sudden Death 07/2006
1	Reinfection 11/2004
1	Cross Infection (Nosocomial Infection) 11/2004
1	Virus Diseases (Viral Diseases) 05/2003
1	T-Cell Lymphoma (Lymphoma, T Cell) 05/2003
1	Staphylococcal Infections 09/2002

Drug/Important Bio-Agent (IBA)

31	Pharmaceutical PreparationsIBA 04/2022 - 09/2002
18	Anti-Bacterial Agents (Antibiotics)IBA 10/2020 - 09/2002
8	Thioridazine (Mellaril)FDA LinkGeneric 01/2017 - 11/2004
5	Rifampin (Rifampicin)FDA LinkGeneric 01/2015 - 09/2005
5	Member 1 Subfamily B ATP Binding Cassette TransporterIBA 12/2011 - 06/2009
4	Isoniazid (Ftivazide)FDA LinkGeneric 01/2022 - 01/2012
4	lipoarabinomannan (LAM)IBA 01/2017 - 11/2014
4	phenothiazineIBA 05/2012 - 03/2003
3	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2019 - 12/2010
3	Ethidium (Ethidium Bromide)IBA 01/2016 - 10/2009
3	Rhodamine 123IBA 01/2016 - 10/2009
3	Chlorpromazine (Thorazine)FDA Link 12/2011 - 11/2004
3	Antipsychotic Agents (Antipsychotics)IBA 12/2011 - 11/2004
3	PhenothiazinesIBA 04/2010 - 11/2004
3	Verapamil (Calan)FDA LinkGeneric 12/2009 - 05/2003
2	Proteins (Proteins, Gene)FDA Link 01/2021 - 03/2005
2	MicroRNAs (MicroRNA)IBA 04/2020 - 01/2019
2	Antitubercular AgentsIBA 03/2019 - 01/2017
2	Genetic Markers (Genetic Marker)IBA 06/2017 - 12/2015
2	Adenosine Triphosphate (ATP)IBA 01/2016 - 06/2009
2	1,3- dimethyl- 1,3- bis(4- fluorophenyl)- 1,3- bis(3- (1- (4- butypiperazinyl))propyl)disiloxaneIBA 05/2013 - 05/2009
2	HydantoinsIBA 10/2011 - 12/2010
2	ATP-Binding Cassette Transporters (ABC Transporters)IBA 10/2009 - 06/2009
2	Reserpine (Serpasil)FDA Link 01/2008 - 09/2002
1	Streptomycin (Streptomycin Sulfate)FDA Link 12/2021
1	Proteoglycans (Proteoglycan)IBA 04/2020
1	dolutegravirIBA 01/2020
1	PowdersIBA 05/2019
1	Hyaluronic Acid (Hyaluronan)IBA 05/2019
1	carbamoylpyridoxal 5'-phosphate (CPLP)IBA 01/2019
1	Indicators and Reagents (Reagents)IBA 01/2019
1	PyrrolidinesIBA 01/2019
1	CytokinesIBA 01/2019
1	usnic acidIBA 11/2018
1	Anti-Infective Agents (Microbicides)IBA 11/2018
1	Colistin (Coly-Mycin)FDA Link 01/2018
1	2-aminothiazoleIBA 01/2018
1	Linezolid (Zyvox)FDA Link 11/2016
1	VaccinesIBA 02/2016
1	Fluorescent Dyes (Fluorescent Probes)IBA 01/2016
1	CarbocyaninesIBA 01/2016
1	3,3'-diethyloxacarbocyanineIBA 01/2016
1	ElementsIBA 01/2016
1	Coloring Agents (Dyes)IBA 01/2016
1	Ion Channels (Ion Channel)IBA 01/2016
1	AcidsIBA 01/2015
1	GoldIBA 05/2014
1	N-acetyltalosaminuronic acid (NAT)IBA 01/2014
1	Nucleic AcidsIBA 01/2014
1	Ethionamide (Trecator-SC)FDA Link 08/2013
1	AminoglycosidesIBA 01/2013
1	Antineoplastic Agents (Antineoplastics)IBA 12/2011
1	Biological ProductsIBA 12/2010
1	MacrolidesIBA 12/2009
1	Azithromycin (Zithromax)FDA LinkGeneric 12/2009
1	Clarithromycin (Biaxin)FDA LinkGeneric 12/2009
1	Disinfectants (Biocides)IBA 10/2009
1	EnzymesIBA 05/2009
1	Ouabain (G Strophanthin)IBA 01/2008
1	Tetracycline (Achromycin)FDA LinkGeneric 07/2007
1	Tuberculin (PPD)IBA 03/2005
1	Vancomycin FDA LinkGeneric 11/2004
1	Plant ExtractsIBA 05/2003

Therapy/Procedure

19	Therapeutics 01/2020 - 03/2003
4	Drug Therapy (Chemotherapy) 01/2016 - 05/2003
1	Retreatment 12/2021
1	Traction 01/2019